Journal of Clinical Oncology, Vol 16, 3731-3735, Copyright © 1998 by American Society of Clinical Oncology

ARTICLES

Inflammatory breast cancer and body mass index

S Chang, AU Buzdar and SD Hursting
Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston 77030-4095, USA. schang@mdacc.tmc.edu

PURPOSE: No studies have investigated the etiology of inflammatory breast cancer (IBC), the most lethal form of breast cancer. Because high body mass index (BMI) is associated with decreased risk of premenopausal breast cancer but increased risk of postmenopausal breast cancer, we evaluated whether high BMI was a risk factor for IBC. PATIENTS AND METHODS: In a case-comparison study, we matched by ethnicity and registration date 68 IBC patients treated at The University of Texas M.D. Anderson Cancer Center from 1985 to 1996 with 143 patients with non-IBC and 134 patients with cancer at sites other than the breast or reproductive tract (non-breast cancer). The non- breast cancer group was used in lieu of a population-based, healthy control group, which was not available. RESULTS: IBC patients were younger at menarche and the time of their first live birth than non-IBC and non-breast cancer patients. The proportion of premenopausal IBC patients was higher than the proportion of premenopausal women in the comparison groups, although differences were not significant. There were no differences in height, but IBC patients were heavier (77.6 kg) than non-IBC (70.0 kg) and non-breast cancer patients (68.0 kg). After adjusting for other factors, women in the highest BMI tertile (BMI > 26.65 kg/m2) relative to the lowest tertile (BMI < 22.27) had significantly increased IBC risk (IBC v non-IBC, odds ratio [OR] = 2.45, 95% confidence interval [CI] = 1.05 to 5.73; IBC v non-breast cancer, OR = 4.52, 95% CI = 1.85 to 11.04). This association was not significantly modified by menopausal status and was independent of age at menarche, family history of breast cancer, gravidity, smoking status, and alcohol use. CONCLUSION: Our investigation showed that high BMI was significantly associated with an increased risk of IBC. This association did not vary by menopausal status, although IBC patients were more likely to be premenopausal. Confirming our findings and identifying other IBC risk factors may provide directions for future research on the aggressive nature of IBC.

This article has been cited by other articles:

				S. Dawood, K. Broglio, A. M. Gonzalez-Angulo, S.-W. Kau, R. Islam, G. N. Hortobagyi, and M. Cristofanilli Prognostic Value of Body Mass Index in Locally Advanced Breast Cancer Clin. Cancer Res., March 15, 2008; 14(6): 1718 - 1725. [Abstract] [Full Text] [PDF]

				S. I. Labidi, K. Mrad, A. Mezlini, M. A. Ouarda, J. D. Combes, M. B. Abdallah, K. B. Romdhane, P. Viens, and F. B. Ayed Inflammatory breast cancer in Tunisia in the era of multimodality therapy Ann. Onc., March 1, 2008; 19(3): 473 - 480. [Abstract] [Full Text] [PDF]

				K. B. Michels, K. L. Terry, and W. C. Willett Longitudinal Study on the Role of Body Size in Premenopausal Breast Cancer Arch Intern Med, November 27, 2006; 166(21): 2395 - 2402. [Abstract] [Full Text] [PDF]

				K. W. Hance, W. F. Anderson, S. S. Devesa, H. A. Young, and P. H. Levine Trends in Inflammatory Breast Carcinoma Incidence and Survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute J Natl Cancer Inst, July 6, 2005; 97(13): 966 - 975. [Abstract] [Full Text] [PDF]